HSC News January 13, 2005
Media/Communications · HSC Online News
 
In this issue:

1.Construction Update.

2. In the News

3. Stem cell therapy: USF/VA study shows cord blood cells limit heart attach damage in animal models.

4. Medicare HMOs fail to control cost of colon surgery for elderly.

5. COPH alum helps readers across the country.

6. Caregivers providing end-of-life care need attention, support.

7.USF and TGH community lecture: Top bioethics expert Arthur Caplan to speak on dying in America.

8..COM students celebrate diversity with fiesta.

9..Mini-Med School schedule.


 

Construction Update

Progress continues for the new College of Nursing building. In fact, construction is about 60 percent complete, said Rick Lyttle of USF Facilities Planning. The metal framing of the new space is complete, dry wall will start to go up on the interior walls, and workers have already started installing the large glass wall that makes up most of the north side of the building. The new building is on schedule (despite four hurricanes) and is due to be complete in May. Then renovations on the existing College of Nursing building will begin in June and should be finished in December. Meanwhile, the renovations to the USF Medical Clinic lobby are finished and the space is due to reopen by the end of January. Photo by John Lofreddo.


Return to top


In the News

Stephen Klasko, MD, MBA, dean of the USF College of Medicine and vice president for Health Sciences was profiled in the Nov. 26 Tampa Bay Business Journal. Dr. Klasko discussed USF's reinvigorated efforts to link academic physicians and researchers with their counterparts in the community.

USF neurologist Juan Sanchez-Ramos, MD, PhD, commented on the significance of USF being designated a Center of Excellence by the Huntington's Disease Society of America in the Nov. 22 Medical News Today. USF's work with patients and families with Huntington's was also featured Nov. 29 on Bay News 9, Dec. 1 in the St. Petersburg Times, and Dec. 19 in the Tampa Tribune.

The announcement of a $2.85 million gift to support USF College of Medicine Alzheimer's disease research with the Johnnie Byrd Alzheimer's Center & Research Institute was covered Dec. 8 by Newschannel 8, ABC Action News Ch. 28, Bay News 9 and the Tampa Bay Business Journal. The gift, from a trust established by the late Pasco County cattle rancher James Porter, was also highlighted Dec. 9 in the Tampa Tribune and St. Petersburg Times.



Several USF Health Sciences Center experts commented for a Dec. 13 St. Petersburg Times cover story on reversals of medical study claims. Stephen Klasko, MD, MBA, dean of medicine and vice president for health sciences; Donna Petersen, ScD, dean of public health; and Paul Wallach, MD, associate dean for curriculum and medical education; discussed how the speed of information, release of preliminary studies and increased expectations for perfect drugs may contribute to errors in scientific research.

USF doctors were sought as experts by local media when news about increased risks of a class of arthritis drugs known as Cox-2 inhibitors broke. Frank Vasey, MD, chief of rheumatology, was interviewed in the Dec. 18 St. Petersburg Times after the FDA cautioned Celebrex users about increased side effect risks. Rheumatologist John Carter, MD, commented on concerns over the safety of painkillers in the Dec. 22 St. Petersburg Times. Kevin Sneed, PharmD, clinical pharmacist, cautioned against panic when drug warnings are issued in the Dec. 28 Tampa Tribune.

Nursing professor Susan McMillan, PhD, RN, commented for a Dec. 18 Miami Herald article on hospice and end-of-life care. Dr. McMillan spoke about USF's initiative in response to a NIH recommendation that doctors receive better training to communicate empathetically with dying patients and their families.

Surgeon Michel Murr, MD, commented Dec. 20 for Reuters Health about a USF study showing the costs of colon surgery for enrollees in Medicare HMOs are no lower than those of similar patients with traditional Medicare. A Dec. 25 Bradenton Herald story on bariatric surgery featured Dr. Murr and one of his patients.

James Studnicki, ScD, a professor of public health who specializes in health outcomes research, commented in the Dec. 21 Tampa Tribune on the suspensions of nine cardiologists who conduct angioplasties at a regional medical center in Hudson. He also discussed trends in angioplasty utilization with WTTA WB-38.

W. McDowell Anderson, MD, sleep disorders specialist, spoke about the effect of sleep apnea on heart rate in the Dec. 28 Tampa Tribune. He commented following the death of retired NFL superstar Reggie White, who was affected by the breathing disorder. Dr. Anderson also appeared on WTTA WB-38 and Fox 13's Good Day Tampa Bay.

Daniel Buffington, PharmD, who teaches pharmacology at the College of Medicine, was quoted for a Dec. 29 USA Today article on over-the-counter hangover remedies. "It's definitely buyer beware," Dr. Buffington said, because the supplements do not receive the same FDA scrutiny as prescription drugs.

By Anne DeLotto Baier
abaier@hsc.usf.edu

Return to top


Stem cell therapy for ailing hearts

USF/VA study shows cord blood cells limit heart attach damage in animal models
By Anne DeLotto Baier

Stem cells from umbilical cord blood effectively treated heart attacks in an animal study, report cardiologist Robert J. Henning, MD, and colleagues at USF and James A. Haley Veterans' Hospital.
When injected into rats' hearts soon after a heart attack, stem cells taken from human umbilical cord blood (HUCB) greatly reduced the size of heart damage and restored pumping function to near normal. This improvement occurred without the need for drugs to prevent the rats' immune system from rejecting the human cells.

The USF study was published online earlier this month in the journal Cell Transplantation, accompanied by an editorial discussing the progress of stem cell therapy in treating heart attacks, or myocardial infarctions.

From left to right, Alison Willing, PhD; Robert Henning, MD; and Paul Sanberg, PhD, DSc, are exploring the potential of cord blood stem cells to reduce heart attack damage. Photo by Eric Younghans.
If further animal studies and human clinical trials prove equally successful, the USF researchers suggest that stem cells from umbilical cord blood could be a new, widely applicable treatment for limiting or repairing the heart muscle destroyed when the vital organ's blood supply is cut off. In the United States, nearly one of every two men and one of three women older than age 40 will suffer a heart attack, leaving them more vulnerable to chronic heart failure or another, potentially fatal, heart attack. Medications and bypass surgery have prolonged the lives of these patients, but many live with heart failure characterized by chronic fatigue and shortness of breath.

"Patients with heart failure due to heart attacks and other causes spend much of their day at home in a chair or in bed. These are the patients whose lives we hope to greatly improve with stem cell therapy to restore heart function," said Dr. Henning, lead author of the study. "Our initial results are extremely promising, but raise questions about how these umbilical cord blood cells work. Are they transforming into new heart muscle cells or secreting growth factors that trigger the heart to repair itself? We need more research to insure such therapy will ultimately benefit patients with little or no side effects."

"The possibility to regenerate and to restore function of the heart after myocardial infarction with stem cell transplantation holds great promise for treating heart failure," wrote David Stern, MD, dean of the Medical College of Georgia, and colleagues in the Cell Transplantation editorial accompanying the USF study. "Additional preclinical animal studies are warranted and should focus on examining the mechanisms that mediate the functional effects of stem cell transplantation."

The USF work adds to a growing field exploring the potential of stem cells to treat ailing hearts. Animal and human cell transplantation to treat heart attacks has focused primarily on immature cells harvested from adult bone marrow and skeletal muscle – with mixed results.

"Cord blood stem cells may be more amenable to repairing hearts. In addition, cord blood stem cells are readily accessible, easy to use, and, like adult stem cells, are not as controversial as embryonic stem cells." said coauthor Paul R. Sanberg, PhD, DSc, director of the USF Center of Excellence for Aging and Brain Repair.

Other authors of the study were Hamdi Abu-Ali; MD; John Balis, MD; Michael B. Morgan, MD; and Alison E. Willing, PhD. The USF study was supported by the American Heart Association, the Veterans Administration, a Florida Biomedical Research Grant, and Saneron CCEL Therapeutics, Inc., a USF spin-out biotechnology company focusing on developing stem cell therapies for debilitating or deadly diseases. Some study authors are affiliated with Saneron and are co-inventors on related patent applications by USF.

Return to top

Medicare HMOs fail to control cost of colon surgery for elderly

By Anne DeLotto Baier

The costs of caring for elderly Florida patients hospitalized for colon surgery are not reduced by Medicare HMOs, a USF paper in the December issue of the Archives of Surgery reports. Despite significantly shorter hospital stays, Medicare HMO beneficiaries who underwent colon resections — surgery to remove a diseased section of the large intestines — incurred the same overall hospital charges as patients covered by traditional fee-for-service Medicare. Consequently, the study found, daily hospital charges for the Medicare HMO group were higher than for the traditional Medicare group. The researchers assumed a direct relationship between hospital charges, available from the Agency for Health Care Administration's Florida database, and actual costs, which are difficult to obtain from hospital executives.

"The Medicare HMO model failed as a cost-saving measure in this particular instance," said the study's principal investigator Michel Murr, MD, a USF associate professor of surgery. "Our finding appears to be confirmed by the recent departure of major HMOs from the Medicare market in Florida."

Dr. Murr and his research team, headed by Dr. Jimmy Sung, examined the outcomes of all colon resections for patients age 70 and older in Florida from 1995 to 1999. Colon resection, usually performed to remove cancer, treat diverticulitis or remove a bowel blockage, is the most common abdominal surgery in elderly patients. Regardless of the type of Medicare coverage, the researchers noted a 10 to 30 percent increase in hospital charges for colon resections in the four-year study period. The intention of Medicare HMOs is to reduce waste in the system by trying to eliminate unnecessary and inappropriate care, while giving providers incentives to use cost-efficient care.

"Medicare HMO patients typically have shorter hospital stays and less secondary illnesses like diabetes, hypertension and pulmonary diseases," Dr. Murr said. "You'd expect operating on these healthier patients would result in lower charges – but it does not."

Results of the Florida study were similar to other studies that have concluded rates of high-cost surgical procedures were not reduced among Medicare HMO enrollees. More research is warranted to determine why daily hospital charges were higher for the Medicare HMO group, Dr. Murr said. "Unless we adequately plan for an ever-growing population of elderly surgical patients, our health care expenditures will continue to skyrocket."

Return to top

COPH alum helps readers across the country

  COPH alum Cynthia Sass, MPH, RD, is in the spotlight again, this time with the national magazine Cooking Light. In the December issue, Sass, a registered dietician, helped elucidate the science of sugar, and in the January/February issue she outlined multivitamins to help readers choose one that's right for them. Both articles were authored by Sass and both mention her continued connection with USF. Last spring, she made headlines with her first book, "Your Diet is Driving Me Crazy" (Marlowe & Co.). Sass graduated from USF with an MPH in Health Education and is a spokesperson for the American Dietetic Association.
Return to top

Caregivers providing end-of-life care need attention, support

By Anne DeLotto Baier

Caregivers of cancer patients dying at home benefited from supportive educational sessions in which hospice nurses taught the caregivers how to cope with distressing patient symptoms, a USF nursing professor reported at the recent National Institutes of Health conference on end-of-life care. Susan McMillan, PhD, RN, a member of USF's Center for Hospice, Palliative Care and End-of-Life Studies and the Collaborative on Aging, was among the researchers to speak Dec. 6 to 8 at the NIH State of the Science Conference on Improving End-of-Life Care. She joined presenters from Harvard, Johns Hopkins, Duke, Stanford and other top universities in helping the NIH panel set the federal research agenda for end-of-life care over the next decade.

Dr. McMillan led one of the few randomized clinical trials conducted with caregivers of patients near the end of life. She shared the findings by a team of researchers at the USF College of Nursing, the USF School of Aging Studies, the USF Division of Geriatric Medicine, the H. Lee Moffitt Cancer Center, and LifePath Hospice Inc. The Tampa study, funded by the National Cancer Institute and the National Institute for Nursing Research, looked at the effects of a psychoeducational intervention for family members caring for terminally ill cancer patients at home.

In the study, in addition to providing standard hospice care, nurses taught family caregivers how to better assess and cope with specific cancer symptoms such as pain, constipation and difficulty breathing. The researchers compared this group to caregivers of patients receiving hospice care alone and caregivers of patients receiving hospice care and supportive visits. Dr. McMillan found that with interventions, caregiver quality of life increased while the burden from caregiving, and caregiver distress were significantly reduced.

"There has been little prior data to describe which caregivers are at greatest risk for distress and which interventions are likely to relieve that distress," Dr. McMillan said. "Our NIH-funded study found that caregivers benefited from even a small number of sessions with the interventionists, above and beyond the benefits gained from hospice care alone."

Another NIH study directed by Dr. McMillan is evaluating the effectiveness of a coping intervention for caregivers of patients being treated for cancer pain. While the first intervention session is offered during a home visit, subsequent sessions are conducted by telephone. Family caregivers are central to end-of-life care because they offer emotional support, help with activities of daily living and medications, and communicate with health care professionals about the patient's condition. Yet, caregivers — many of whom are elderly spouses with their own health problems — may experience significant strain and anxiety — from taking care of seriously ill patients, Dr. McMillan said.

"In today's health care system, patients simply don't have the option of being hospitalized for long periods, including at the end of life," she said. "And, most patients tell you they want to be able to die comfortably at home in their own beds. But, that can only happen if we adequately prepare family members to provide extensive care for their loved ones at home."

End-of-life care studies, primarily focused on cancer patients and their caregivers, should be expanded to include caregivers for others nearing end of life, Dr. McMillan said. This would include those with end-stage heart disease, chronic obstructive pulmonary disease and dementia. Researchers also need to determine which caregiver interventions might work best with ethnically and culturally diverse populations, she added. Dr. McMillan's selection as a conference speaker recognized the national prominence of her work and USF's growing stature as a center for research excellence in such areas as aging and end-of-life care, said William Haley, PhD, chair of the Advisory Council for USF's Collaborative on Aging. "Dr. McMillan has done an outstanding job of bringing together a team of researchers with diverse skills to complete a project that caught the attention of the leaders of NIH's end-of-life initiatives."

Return to top


USF and TGH host Jan. 13 community lecture

Top bioethics expert Arthur Caplan to speak on dying in America

Science and medicine are making it increasingly possible to extend life, but is conquering death really an ethical thing to try to do?

Arthur Caplan, PhD, renowned expert on biotechnology and bioethics, will discuss "Can Americans Ever Manage Dying: From Karen Ann Quinlan to Terri Schiavo," Thursday, Jan. 13, at a free community presentation sponsored by the USF Health Sciences Center and Tampa General Hospital.

The event will be from 6 to 7:15 p.m. at the Wyndham Harbour Island Hotel, 725 S. Harbour Island Blvd. in Tampa.
"This is the first lecture in a community-based Ethics and Humanities series we are launching with Tampa General Hospital," said Stephen Klasko, MD, MBA, dean of the College of Medicine and vice president for Health Sciences at USF. "We will bring in nationally recognized leaders in medical ethics and humanities to encourage conversation about critical health care issues that can affect each of us."

"We are pleased to partner with USF to offer this program to our community," said Ron Hytoff, president and CEO of Tampa General Hospital. "This is a unique opportunity for people to hear recognized experts discuss some of the most challenging and complex issues in health care today."

Dr. Caplan is the Emanuel and Robert Hart Professor of Bioethics, chair of the Department of Medical Ethics and director of the Center for Bioethics at the University of Pennsylvania in Philadelphia. He is known for clarifying ethical concerns such as those arising from advances in organ transplantation, reproductive technology, genetics, stem cell research and end-of-life care and explaining their impact on health policy. Dr. Caplan is a frequent commentator on NPR, CNN and MSNBC and has written articles for The New York Times and The Washington Post. He is the author and editor of 24 books, including The Human Cloning Debate and Moral Matters: Ethical Issues in Medicine and the Life Sciences.
For more information, please call 813-974-4296.

Return to top


COM students celebrate diversity with fiesta

The USF College of Medicine is hosting its first cultural fiesta 6:30 p.m. on Saturday, Jan. 22, in the courtyard next to the College of Nursing. This event aims to bring together the students, faculty, family and friends of the USF College of Medicine and to begin a tradition at the college, where cultural diversity is recognized and appreciated, said Gathline Etienne, first-year medical student and a member of the Cultural Fiesta Committee.

The night will feature booths with ethnic decorations and foods. In addition, there will be a showcase of performances from different groups and individuals. The cost of the event is $3, which will be waived if the student or faculty brings a potluck dish. The funds collected from this event will go towards our sponsors, Project World Health, Student National Medical Association (SNMA) and the mission trip to Haiti for the Christian Medical Association.

"So you are invited to a night of cultural fiesta where your life and taste buds will be enriched through this explosion of food, music, laughter, fun and diversity," Etienne said.


Mini-Med School schedule


Click here to register
Return to top


Page Content goes Here.